Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Novavax

Novavax (NASDAQ: NVAX) insider transactions

In the twelve months to 10 November 2026, executives and directors of Novavax reported no open-market sales and no open-market purchases, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Novavax shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
20 June 2026Alton Gregg HDirectorOption exercise+18,880—47,685Form 4
20 June 2026Mott David MDirectorOption exercise+18,880—79,770Form 4
20 June 2026McGlynn Margaret GDirectorOption exercise+18,880—44,468Form 4
20 June 2026Douglas RichardDirectorOption exercise+18,880—73,220Form 4
20 June 2026King Rachel K.DirectorOption exercise+18,880—44,070Form 4
20 June 2026Rodgers Richard JDirectorOption exercise+18,880—47,370Form 4
25 April 2026Newton Charles W.DirectorOption exercise+9,520—9,520Form 4
10 March 2026Shiver John W.DirectorOption exercise+7,947—7,947Form 4
7 March 2026Kelly James PatrickEVP, CFO and TreasurerOption exercise+12,223—136,503Form 4
7 March 2026Kelly James PatrickEVP, CFO and TreasurerShares withheld for tax−5,904$9.98130,599Form 4
3 March 2026Draghia-Akli RuxandraEVP, Research & DevelopmentOption exercise+26,667—34,876Form 4
3 March 2026Draghia-Akli RuxandraEVP, Research & DevelopmentShares withheld for tax−11,313$9.4923,563Form 4
3 March 2026Casey Mark JEVP, Chief Legal OfficerOption exercise+37,500—101,445Form 4
3 March 2026Casey Mark JEVP, Chief Legal OfficerShares withheld for tax−11,378$9.4990,067Form 4
3 March 2026O'Hara ElaineEVP, Chief Strategy OfficerOption exercise+56,334—157,071Form 4
3 March 2026O'Hara ElaineEVP, Chief Strategy OfficerShares withheld for tax−22,429$9.49134,642Form 4
3 March 2026Jacobs John CPresident and CEOOption exercise+150,167—264,130Form 4
3 March 2026Jacobs John CPresident and CEOShares withheld for tax−69,288$9.49225,680Form 4
3 March 2026Kelly James PatrickEVP, CFO and TreasurerOption exercise+43,167—145,130Form 4
3 March 2026Kelly James PatrickEVP, CFO and TreasurerShares withheld for tax−20,850$9.49124,280Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Novavax page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.